Clinical Trial Update: Evaluation of Mesenchymal Stem Cells to Treat Avascular Necrosis of the Hip [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating mesenchymal stem cells for avascular necrosis of the femoral head has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avascular Necrosis of the Femoral Head

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Universidad Autonoma de Madrid | Conditions: Avascular Necrosis of the Femoral Head | Phase 2 | Status: COMPLETED